前往化源商城

N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-异恶唑基)脲

更新时间:2024-01-11 14:32:28

N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-异恶唑基)脲结构式
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-异恶唑基)脲结构式
品牌特惠专场
常用名 N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-异恶唑基)脲 英文名 Tivozanib
CAS号 682745-41-1 分子量 509.33900
密度 N/A 沸点 N/A
分子式 C22H22Cl2N4O6 熔点 N/A
MSDS N/A 闪点 N/A

 用途


Tivozanib hydrochloride hydrate is a potent and selective and orally active VEGFR tyrosine kinase inhibitor with IC50是of 0.21, 0.16, 0.24 nM for VEGFR-1, VEGFR-2, VEGFR-3, respectively. Tivozanib hydrochloride hydrate inhibits angiogenesis and vascular permeability in tumor tissues and shows antitumor activity. Tivozanib hydrochloride hydrate has the potential for the research of metastatic renal cell carcinoma (RCC) [1][2][3].

 名称

中文名 N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-异恶唑基)脲
英文名 1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea,hydrate,hydrochloride
英文别名 更多

 生物活性

描述 盐酸替沃扎尼水合物是一种有效、选择性和口服活性VEGFR酪氨酸激酶抑制剂,具有IC50是分别为0.21、0.16、0.24 nM。盐酸替沃扎尼水合物抑制肿瘤组织中的血管生成和血管通透性,并显示出抗肿瘤活性。盐酸替沃扎尼水合物具有研究转移性肾细胞癌的潜力[1][2][3]。
相关类别
靶点

VEGFR-1:0.21 nM (IC50)

VEGFR-2:0.16 nM (IC50)

VEGFR-3:0.24 nM (IC50)

体外研究 盐酸替沃扎尼水合物抑制VEGFR-1、VEGFR-2和VEGFR-3的磷酸化[2]。
体内研究 盐酸替沃扎尼水合物(1 mg/kg;p.o.;14天)抑制CNV病变的发展,并导致已建立的CNV显著消退,使受影响区域减少67.7%[4]。
参考文献

[1]. Motzer RJ, et al. Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial. J Clin Oncol. 2013 Oct 20;31(30):3791-9.

[2]. De Luca A, et al. Tivozanib, a pan-VEGFR tyrosine kinase inhibitor for the potential treatment of solid tumors. IDrugs. 2010 Sep;13(9):636-45.

[3]. Eskens FA, det al. Biologic and clinical activity of tivozanib (AV-951, KRN-951), a selective inhibitor of VEGF receptor-1, -2, and -3 tyrosine kinases, in a 4-week-on, 2-week-off schedule in patients with advanced solid tumors. Clin Cancer Res. 2011 Nov 15;17(22):7156-63.

[4]. Kang S, et al. Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice. Exp Eye Res. 2013 Jul;112:125-33.

 物理化学性质

分子式 C22H22Cl2N4O6
分子量 509.33900
精确质量 508.09200
PSA 123.69000
LogP 5.81130
储存条件 -20°C

 英文别名

Tivozanib hydrochloride monohydrate
UNII-8A9H4VK35Z
Tivozanib hydrochloride hydrate
Tivozanib HCl hydrate
Kil-8951
Tivozanib HCl